Jakarta, INTI - Indonesian startup HerLens is developing a portable cervical cancer screening device powered by artificial intelligence (AI) to make early detection more affordable and accessible, particularly for women in remote and underserved areas. The innovation aims to address barriers to screening, including limited healthcare facilities, high examination costs, and a lack of awareness about the importance of regular cervical health checks.
By combining AI technology with a portable device, HerLens hopes to support preliminary screening and bring healthcare services closer to communities that have limited access to specialized medical facilities. The initiative reflects the growing potential of technology to address healthcare challenges while improving opportunities for early detection.
Expanding Access to Early Detection
Cervical cancer remains a significant public health concern in Indonesia. According to figures cited in the original report, the country records approximately 36,000 new cases and 21,000 deaths annually. Limited access to screening services can make early detection difficult, especially for women who live far from hospitals or healthcare centers equipped to provide specialized examinations.
HerLens aims to address these challenges by developing a screening solution that is designed to be more practical and accessible. A portable device could potentially help healthcare providers reach more communities and expand screening opportunities beyond major urban centers. The use of AI is intended to support the screening process, although the device's diagnostic performance and clinical effectiveness will need to be established through appropriate testing and validation.
Improving access to screening is particularly important because early detection can help identify potential health concerns before they progress. Alongside technological development, public education and greater awareness of cervical cancer screening remain essential to encouraging women to seek timely medical examinations.
A Personal Mission to Improve Women's Healthcare
HerLens was founded by Jihan, whose personal motivation inspired her to develop a technology-based solution for women's health. Through the startup, she aims to address gaps in cervical cancer screening and help make preventive healthcare more accessible to women across Indonesia.
The development of a portable AI-powered device reflects a broader effort to apply digital innovation to practical healthcare needs. Rather than relying solely on conventional healthcare infrastructure, solutions such as HerLens could potentially support screening initiatives in areas where access to specialized services remains limited. However, the technology is still under development, and its potential role in clinical settings will depend on further evaluation, safety testing, and collaboration with healthcare professionals.
HerLens has also been named a finalist in the Unlock Her Future 2026 competition, which offers the possibility of funding of up to US$100,000. The opportunity could help support the startup's development efforts as it works to advance its technology and explore its potential application in women's healthcare.
Advancing AI Innovation in Healthcare
The development of HerLens highlights how startups can use AI to explore solutions for persistent healthcare challenges. In Indonesia, expanding access to screening services requires not only technological innovation but also adequate healthcare infrastructure, trained personnel, and public awareness.
If successfully developed and clinically validated, HerLens could contribute to efforts to make preliminary cervical cancer screening more accessible, particularly in underserved communities. Further testing will be crucial to determine the device's accuracy, reliability, and suitability for use in real-world healthcare environments.
As the startup continues its development journey, its progress could demonstrate how locally developed health technology may help address gaps in preventive care. The broader goal is to ensure that more women have opportunities to access screening services and receive appropriate medical follow-up when needed.
Conclusion
HerLens is developing an AI-powered cervical cancer screening device with the aim of improving access to early detection in Indonesia. By focusing on affordability and portability, the startup hopes to address screening barriers faced by women in remote and underserved areas. Its recognition in the Unlock Her Future 2026 competition could provide further support for its development. However, clinical validation and effective implementation will be essential before the technology can deliver its intended benefits to patients.
Read more: BPOM and China Set to Sign MoU, Expanding Cooperation on Vaccines and Technology Transfer